IN8bio, Inc. (INAB) Earnings Report - Discounting Cash Flows
INAB
IN8bio, Inc.
INAB (NASDAQ)
Period Ending: 2026
03-12
2025
11-06
2025
08-07
2025
05-07
2025
03-13
2024
11-12
2024
08-08
2024
05-09
2024
03-14
2023
11-09
2023
08-10
2023
05-12
2023
03-30
2022
11-10
2022
08-12
2022
05-12
2022
03-17
2021
11-10
2021
09-10
2021
07-30
2020
12-30
2020
09-29
2020
06-29
2020
03-30
2019
12-30
2019
09-29
2019
06-29
2019
03-30
2018
06-29
2018
03-30
Actual EPS - -0.85 -1.24 -2.10 -0.04 -0.15 -0.19 -0.20 -0.21 -0.23 -0.27 -0.30 -0.32 -0.34 -0.38 -0.33 -0.21 -0.25 -0.16 -0.16 -0.12 -0.09 -0.19 -0.11 -0.48 -0.48 -0.16 -0.16 -0.08 -0.08
Estimated EPS -0.18 -1.20 -1.50 -1.80 -0.07 -0.14 -0.16 -0.17 -0.16 -0.25 -0.28 -0.33 -0.28 -0.28 -0.33 -0.34 -0.21 -0.33 -0.30 - - - - - - - - - - -
Actual Revenue - - - - - - - - 3.75 - - - - - - - - - - - - - - - - - - - - -
Estimated Revenue - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program